Your browser doesn't support javascript.
loading
Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.
Krueger, Janna; Santinon, Francois; Kazanova, Alexandra; Issa, Mark E; Larrivee, Bruno; Kremer, Richard; Milhalcioiu, Catalin; Rudd, Christopher E.
Afiliação
  • Krueger J; Division of Immuno-Oncology, Research Center Maisonneuve-Rosemont Hospital (CR-HMR) Montreal, Quebec, Canada.
  • Santinon F; Department of Microbiology, Infection and Immunology, Universite de Montreal, Montreal, Quebec, Canada.
  • Kazanova A; Division of Immuno-Oncology, Research Center Maisonneuve-Rosemont Hospital (CR-HMR) Montreal, Quebec, Canada.
  • Issa ME; Department of Microbiology, Infection and Immunology, Universite de Montreal, Montreal, Quebec, Canada.
  • Larrivee B; Division of Immuno-Oncology, Research Center Maisonneuve-Rosemont Hospital (CR-HMR) Montreal, Quebec, Canada.
  • Kremer R; Department of Microbiology, Infection and Immunology, Universite de Montreal, Montreal, Quebec, Canada.
  • Milhalcioiu C; Division of Immuno-Oncology, Research Center Maisonneuve-Rosemont Hospital (CR-HMR) Montreal, Quebec, Canada.
  • Rudd CE; Department of Microbiology, Infection and Immunology, Universite de Montreal, Montreal, Quebec, Canada.
PLoS One ; 16(6): e0251731, 2021.
Article em En | MEDLINE | ID: mdl-34181666
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico / Hidroxicloroquina / Imunoterapia Limite: Animals Idioma: En Revista: PLoS One Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico / Hidroxicloroquina / Imunoterapia Limite: Animals Idioma: En Revista: PLoS One Ano de publicação: 2021 Tipo de documento: Article